Stereotactic ablative radiotherapy for stage I NSCLC: Recent advances and controversies

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)189-196
JournalJournal of Thoracic Disease
Volume3
Issue number3
DOIs
Publication statusPublished - 2011

Cite this

@article{a72a96bc553a4346b86e774debd4448f,
title = "Stereotactic ablative radiotherapy for stage I NSCLC: Recent advances and controversies",
author = "S. Senan and D.A. Palma and F.J. Lagerwaard",
year = "2011",
doi = "10.3978/j.issn.2072-1439.2011.05.03",
language = "Undefined/Unknown",
volume = "3",
pages = "189--196",
journal = "Journal of Thoracic Disease",
issn = "2072-1439",
publisher = "Pioneer Bioscience Publishing Company (PBPC)",
number = "3",

}

Stereotactic ablative radiotherapy for stage I NSCLC: Recent advances and controversies. / Senan, S.; Palma, D.A.; Lagerwaard, F.J.

In: Journal of Thoracic Disease, Vol. 3, No. 3, 2011, p. 189-196.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Stereotactic ablative radiotherapy for stage I NSCLC: Recent advances and controversies

AU - Senan, S.

AU - Palma, D.A.

AU - Lagerwaard, F.J.

PY - 2011

Y1 - 2011

U2 - 10.3978/j.issn.2072-1439.2011.05.03

DO - 10.3978/j.issn.2072-1439.2011.05.03

M3 - Article

VL - 3

SP - 189

EP - 196

JO - Journal of Thoracic Disease

JF - Journal of Thoracic Disease

SN - 2072-1439

IS - 3

ER -